Literature DB >> 16935569

Overshadowing and latent inhibition of context aversion conditioning in the rat.

Geoffrey Hall1, Michelle Symonds.   

Abstract

A review is presented of experimental studies, using rats as the subjects, that were designed to establish an animal model of the clinical phenomenon of anticipatory nausea. Experiments 1 and 2 demonstrated that pairing a distinctive context with an illness-inducing injection of lithium chloride endowed the context with new properties, consistent with the proposal that classical conditioning had established an association between the context as the conditioned stimulus and nausea as the unconditioned stimulus. The conditioned response to the context constitutes a form of anticipatory nausea. Experiment 3 examined overshadowing, showing that the presence of a novel salient cue (a flavour) during context conditioning reduced the magnitude of the aversion conditioned to the context. Experiments 4-7 examined the effects of giving exposure to the context prior to conditioning. They demonstrated a latent inhibition effect, that is, a reduction in the magnitude of the aversion in pre-exposed animals. It is suggested that these ways of modulating conditioned aversions could form the basis of interventions for use in the chemotherapy clinic. Anticipatory nausea is assumed to be a consequence of the formation of an association between the cues that constitute the clinic and the drug-induced nausea experienced in their presence. By restricting the development of this association, latent inhibition and overshadowing procedures should be effective in alleviating the problem of anticipatory nausea.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935569     DOI: 10.1016/j.autneu.2006.07.013

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  9 in total

1.  Serial overshadowing of taste aversion learning by stimuli preceding the target taste.

Authors:  Dorothy W S Kwok; Evan J Livesey; Robert A Boakes
Journal:  Learn Behav       Date:  2012-12       Impact factor: 1.986

2.  Episodic memory updating: the role of context familiarity.

Authors:  Almut Hupbach; Rebecca Gomez; Lynn Nadel
Journal:  Psychon Bull Rev       Date:  2011-08

Review 3.  Anticipatory nausea and vomiting due to chemotherapy.

Authors:  Charles Kamen; Mohamedtaki A Tejani; Kavita Chandwani; Michelle Janelsins; Anita R Peoples; Joseph A Roscoe; Gary R Morrow
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

Review 4.  Anticipatory nausea and vomiting.

Authors:  Joseph A Roscoe; Gary R Morrow; Matti S Aapro; Alexander Molassiotis; Ian Olver
Journal:  Support Care Cancer       Date:  2010-08-30       Impact factor: 3.603

Review 5.  Opportunities for the replacement of animals in the study of nausea and vomiting.

Authors:  A M Holmes; J A Rudd; F D Tattersall; Q Aziz; P L R Andrews
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 6.  Role of classical conditioning in learning gastrointestinal symptoms.

Authors:  Ursula Stockhorst; Paul Enck; Sibylle Klosterhalfen
Journal:  World J Gastroenterol       Date:  2007-07-07       Impact factor: 5.742

7.  Evaluation of ambiguous associations in the amygdala by learning the structure of the environment.

Authors:  Tamas J Madarasz; Lorenzo Diaz-Mataix; Omar Akhand; Edgar A Ycu; Joseph E LeDoux; Joshua P Johansen
Journal:  Nat Neurosci       Date:  2016-05-23       Impact factor: 24.884

8.  Sex and Age Differences in Motion Sickness in Rats: The Correlation with Blood Hormone Responses and Neuronal Activation in the Vestibular and Autonomic Nuclei.

Authors:  Wei Zhou; Junqin Wang; Leilei Pan; Ruirui Qi; Peng Liu; Jiluo Liu; Yiling Cai
Journal:  Front Aging Neurosci       Date:  2017-02-15       Impact factor: 5.750

9.  Overshadowing as prevention of anticipatory nausea and vomiting in pediatric cancer patients: study protocol for a randomized controlled trial.

Authors:  Friedemann Geiger; Levke Wolfgram
Journal:  Trials       Date:  2013-04-20       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.